Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Market Cap	1.63B -24.8%
Revenue (ttm)	482.03M -1.9%
Net Income	3.26M -99.2%
EPS	0.03 -99.4%
Shares Out	118.74M
PE Ratio	499.75
Forward PE	n/a
Dividend	0.50 (3.65%)
Ex-Dividend Date	Sep 24, 2025

Volume	160,376
Average Volume	259,379
Open	13.75
Previous Close	13.75
Day's Range	13.65 - 13.80
52-Week Range	13.60 - 23.10
Beta	-0.00
RSI	27.79
Earnings Date	Mar 27, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4109

Financial Performance

In 2024, Jia Jie Biomedical's revenue was 537.07 million, an increase of 61.40% compared to the previous year's 332.76 million. Earnings were 211.37 million, an increase of 46.64%.